placeholder image
R. J. Threlkeld All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 2 diabetes currently treated with basal insulin (QWINT-3): a phase 3, randomised, non-inferiority trial. 
    Lancet (London, England). 2025
    • Contact
    full name
  • R. J. Threlkeld
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration